@article{75549fa807c4480aa8f10acb0ee1263a,
title = "Oral Anticoagulation and antithrombotic Therapy in Patients with Atrial Fibrillation after percutaneous Coronary Intervention - with special Reference to Dabigatran",
keywords = "RIVAROXABAN, METAANALYSIS, PREVENTION, APIXABAN, EFFICACY, WARFARIN, STROKE, SAFETY",
author = "K Huber and \{Delle Karth\}, G and H Frank and T Gremmel and C Madl and A Niessner and T Neunteufl and W Pirker and B Watschinger and F Weidinger and T Weiss and Uta Hoppe and J Auer and RK Binder and P Siostrzonek and C Steinwender and T Sturmberger and M Vosko and H Wallner and R Zweiker and H Alber and K Dritan and A Kirsch and M Kneihsl and R Raggam and D Scherr and V Stadlbauer-Kollner and A Zirlik",
note = "Hoppe: Paracelsus Med Univ Salzburg, Univ Klin Innere Med 2, Salzburg, Austria; Lehr-KH: Krankenhaus St Josef Braunau, Innere Med Kardiol Interne Intens Med *** Akutgeria, Braunau, Austria;",
year = "2020",
language = "Deutsch",
volume = "27",
pages = "3--12",
journal = "Journal f{\"u}r Kardiologie",
issn = "1024-0098",
publisher = "Krause \& Pachernegg GmbH",
}